The Ehrlich Group has filed approximately 30 patent applications for coronavirus-related technologies, on behalf of dozens of Israeli entrepreneurs.
More Articles
Necessity is the Mother of Invention
Gal Ehrlich, Founder and Managing Director of the Ehrlich Group, discusses ...
Israeli research: ‘Natural compounds’ could kill COVID-19 spike protein
The news comes against the backdrop of both skyrocketing infection in ...
Tel Aviv Regional Labor Tribunal Rejected a Claim for Patent Royalties By Employee Inventor
The Tel Aviv Regional Labor Tribunal recently rejected a chemist’s claim to ...
